Brain volume loss in radiologically isolated syndromes compared with early stages of multiple sclerosis patients under DMD treatment

被引：0
|
作者：
Rojas, J. I. [1 ]
Sanchez, F. [1 ]
Caro, F. [1 ]
Miguez, J. [1 ]
Patrucco, L. [1 ]
Cristiano, E. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P854
引用
收藏
页码：440 / 441
页数：2
相关论文
共 50 条
  • [41] Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy
    Slezakova, Darina
    Kadlic, Pavol
    Jezberova, Michaela
    Bolekova, Veronika
    Valkovic, Peter
    Minar, Michal
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (03) : 282 - 288
  • [42] Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide
    Sprenger, Till
    Kappos, Ludwig
    Radue, Ernst-Wilhelm
    Gaetano, Laura
    Mueller-Lenke, Nicole
    Wuerfel, Jens
    Poole, Elizabeth M.
    Cavalier, Steven
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1207 - 1216
  • [43] Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review
    Timothy Vollmer
    Lynn Huynh
    Caroline Kelley
    Philip Galebach
    James Signorovitch
    Allitia DiBernardo
    Rahul Sasane
    Neurological Sciences, 2016, 37 : 165 - 179
  • [44] Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review
    Vollmer, Timothy
    Huynh, Lynn
    Kelley, Caroline
    Galebach, Philip
    Signorovitch, James
    DiBernardo, Allitia
    Sasane, Rahul
    NEUROLOGICAL SCIENCES, 2016, 37 (02) : 165 - 179
  • [45] Factors associated with early disease-modifying drug (DMD) treatment initiation in newly diagnosed patients with multiple sclerosis (MS)
    Phillips, A. L.
    Edwards, N. C.
    Frean, M.
    Locklear, J. C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 601 - 601
  • [46] Persistent MRI Lesion Activity and Brain Volume Loss as Predictors of Long Term Disability Progression under Treatment in Relapsing-Remitting Multiple Sclerosis
    Sormani, M. P.
    Kappos, L.
    Piani-Meier, D.
    Haring, D.
    Tomic, D.
    de Stefano, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 325 - 325
  • [47] Persistent MRI lesion activity and brain volume loss as predictors of long term disability progression under treatment in relapsing-remitting multiple sclerosis
    Sormani, M. P.
    Kappos, L.
    Piani-Meier, D.
    Haring, D.
    Tomic, D.
    de Stefano, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 205 - 206
  • [48] Sustained low rate of brain volume loss under long-term fingolimod treatment in relapsing multiple sclerosis: results from the LONGTERMS study
    Radue, E. W.
    Barkhof, F.
    Cohen, J.
    Gottschalk, R.
    Zhang, Y.
    Cappiello, L.
    von Rosenstiel, P.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 261 - 262
  • [49] Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time
    Jacobi, C.
    Haehnel, S.
    Martinez-Torres, F.
    Rieger, S.
    Juettler, E.
    Heiland, S.
    Jarius, S.
    Meyding-Lamade, U.
    Storch-Hagenlocher, B.
    Wildemann, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (12) : 1359 - 1364
  • [50] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndromes (CIS)
    Comi, Giancarlo
    Filippi, Massimo
    NEUROLOGY, 2008, 71 (02) : 153 - 153
12345